In adult cohorts with chronic kidney disease, scholars have found that CRP exacerbated anemia by inhibiting endogenous/exogenous erythropoietin (38, 39), which may contribute to a synergic effect between inflammation and anemia on unfavorable events (39). Here, EPO is linked to anemia (phenotype).